Share of Cost, New Regulator Identified In Allergic Diseases

Sunday, Jun. 3rd 2012 9:17 AM

Researchers have taken a critical step in understanding how allergic reactions occur after identifying a genetic signature for regulation of a key immune hormone, interleukin (IL-13). Scientists from Cincinnati Children’s Hospital Medical Center say the finding opens the potential for new molecular targets to treat allergic disease.

Posted on Sunday, Jun. 3rd 2012 9:17 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.